Benin vs Ghana: Cause of death, by non-communicable diseases, ages 5-14, male
Benin
22.7%
in 2021
Ghana
22.4%
in 2021
Benin rank
136th
Ghana rank
138th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Benin
- Ghana
How they compare
Benin currently reports 22.7% against 22.4% in Ghana, a difference of 0.3%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Ghana ahead.
Benin ranks 136th and Ghana ranks 138th of 185 countries.
Across the 3 decades both report, Benin averaged higher in 1 and Ghana in 2.
Head to head by decade
| Decade | Benin | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.8% | 20.5% | 6.7% | Ghana |
| 2010s | 21.7% | 22.7% | 1.0% | Ghana |
| 2020s | 23.0% | 22.9% | 0.0% | Benin |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Benin or Ghana?
- Benin, at 22.7% against 22.4% in Ghana as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Benin and Ghana?
- 0.3%, with Benin ahead.
- How many years of comparable data are there for Benin and Ghana?
- 6 years are reported by both, from 2000 to 2021.
- How do Benin and Ghana rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Benin ranks 136th and Ghana ranks 138th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.